EX-99.1 2 drr0140_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

 

Dr. Reddy’s Laboratories Ltd.

8-2-337, Road No. 3, Banjara Hills,

Hyderabad - 500 034, Telangana,

India.

CIN: L85195TG1984PLC004507

   
  Tel :+91 40 4900 2900
  Fax :+91 40 4900 2999
  Email :mail@drreddys.com
  www.drreddys.com

 

July 12, 2019

 

Corporate Relationship Department National Stock Exchange of India Ltd.
BSE Limited “Exchange Plaza”
Dalal Street, Fort Bandra-Kurla Complex, Bandra (East),
Mumbai – 400 001 Mumbai – 400 051
Fax Nos.: 022-22723121 / 22723719 Fax Nos.: 022-26598120/ 26598237
   
Scrip Code: 500124 Scrip Code: DRREDDY-EQ

 

Dear Sirs,

Sub: Intimation

 

This is to inform you that the audit of our API Manufacturing Plant 2 at Bollaram, Hyderabad by the US FDA, has been completed today. We have been issued a Form 483 with 5 observations. We will address them comprehensively within the stipulated timeline.

 

This is for your information.

 

With regards,

 

/s/ Sandeep Poddar  
Sandeep Poddar  
Company Secretary  

 

CC:- New York Stock Exchange Inc.(Stock Code :RDY)